Your browser doesn't support javascript.
loading
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients.
Ivison, Geoffrey T; Vendrame, Elena; Martínez-Colón, Giovanny J; Ranganath, Thanmayi; Vergara, Rosemary; Zhao, Nancy Q; Martin, Maureen P; Bendall, Sean C; Carrington, Mary; Cyktor, Joshua C; McMahon, Deborah K; Eron, Joseph; Jones, R Brad; Mellors, John W; Bosch, Ronald J; Gandhi, Rajesh T; Holmes, Susan; Blish, Catherine A.
Afiliación
  • Ivison GT; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Vendrame E; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Martínez-Colón GJ; Program in Immunology, Stanford University School of Medicine, Stanford, CA, United States.
  • Ranganath T; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Vergara R; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Zhao NQ; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Martin MP; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Bendall SC; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Carrington M; Program in Immunology, Stanford University School of Medicine, Stanford, CA, United States.
  • Cyktor JC; Basic Science Program, Frederick National Laboratory for Cancer Research, National, Cancer Institute, Frederick, MD, United States.
  • McMahon DK; Laboratory of Integrative Cancer, Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
  • Eron J; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Jones RB; Basic Science Program, Frederick National Laboratory for Cancer Research, National, Cancer Institute, Frederick, MD, United States.
  • Mellors JW; Laboratory of Integrative Cancer, Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
  • Bosch RJ; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard, Boston, MA, United States.
  • Gandhi RT; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, United States.
  • Holmes S; Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, United States.
  • Blish CA; Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States.
Front Cell Infect Microbiol ; 12: 757846, 2022.
Article en En | MEDLINE | ID: mdl-35223535
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos